The 2026 T20 World Cup has seen its fair share of drama on the field, but a recent off-field outburst from former Pakistan opener Ahmed Shehzad has sparked a massive controversy. During a recent appearance on the talk show ‘Haarna Mana Hai’, Shehzad leveled serious allegations against BCCI and ICC, claiming a lack of transparency in anti-doping protocols for Indian cricketers.
Shehzad’s primary argument was that ICC applies a double standard when it comes to drug testing. His main points included:
Despite the "bombshell" nature of Shehzad's statements, the technical and regulatory reality contradicts his claims:
NADA Integration (2019): In a historic move in 2019, BCCI officially came under the ambit of National Anti-Doping Agency (NADA). This means Indian cricketers are subject to the same WADA-compliant testing as any other international athlete.
ICC Event Protocol: During ICC tournaments like the 2026 T20 World Cup, ICC’s independent Anti-Doping Unit handles testing for all participating teams, including India. No individual board has the authority to bypass these tournament-specific tests.
WADA Oversight: All samples collected from Indian players are processed at WADA-accredited laboratories. The results are transparently shared with the global governing bodies, leaving zero room for a "private board-only" testing loophole.
Experts suggest these comments are part of a broader "blame game" following Pakistan's disappointing early exit from the tournament. With the team facing heavy criticism at home, former players have frequently shifted focus toward the BCCI's influence over the ICC to deflect from the team’s on-field performance.
